Introduction
============

Coenzyme Q~10~ (CoQ~10~) is an important cofactor in the respiratory chain. The reduced form of Coenzyme Q~10~ (ubiquinol) serves as a potent antioxidant in mitochondria and lipid.^([@B1])^ More recently, studies *in vitro*,^([@B2],[@B3])^ in SAMP1 mice^([@B4])^ and in humans^([@B5])^ provide evidence that ubiquinol is involved in inflammatory processes and lipid metabolism via gene expression. Moreover, reducing effects of coenzyme Q~10~ (ubiquinone) have been also described on genes involved in inflammation and hepatic stress-associated processes in the liver of diet-induced obese mice.^([@B6])^ However, when related to the oxidized form of coenzyme Q~10~ (ubiquinone), stronger effects have been observed for the reduced form (ubiquinol) both on the transcriptional^([@B4],[@B7])^ or protein level^([@B8],[@B9])^ *in vitro* and *in vivo*. To study the observed transcriptional effects of reduced coenzyme Q~10~ (ubiquinol) in more mechanistic detail, C57BL6J mice were supplemented for one week with 250 mg/kg BW/d ubiquinol. Afterwards, the resulting gene expression signatures were analyzed in the liver of mice, and DNA methylation patterns within the promoters of regulated genes were evaluated. Epigenetic mechanisms such as DNA methylation have been shown to entail heritable changes in gene expression.^([@B10],[@B11])^ Of note, impacts on DNA methylation processes have been already described for various dietary supplements and food nutrients so far.^([@B12],[@B13])^ DNA methylation consists of the addition of a methyl group to the fifth carbon-position of the cytosine pyrimidine ring in the context of a CpG dinucleotide. Although most genomic DNA in mammals is deficient in CpG sites, clusters of CpG dinucleotides (CpG islands) were described to be primarily located in promoter regions of genes.^([@B14])^ Thus, the present study postulates that ubiquinol affects gene expression by modulating DNA methylation patterns in the respective CpG island promoter regions of the selected genes.

Materials and Methods
=====================

Animals and diet
----------------

C57BL6J mice were reared in the Biochemical and Medical Research Laboratories, KANEKA Corp. (Takasago, Japan), at 22 ± 2°C and a 12 h-light-dark cycle. Water and food intake were available ad libitum. At the beginning of the short-term supplementation study, eight 10-week old male C57BL6J mice were purchased from Charles River Lab. Inc. (Yokohama, Japan). To avoid fighting, mice were housed separately throughout 1-week acclimation period and ubiquinol-supplementation study. In the initial phase of the experiment, C57BL6J mice were randomly assigned to either the ubiquinol (*n* = 4) or control group (*n* = 4). Ubiquinol (KANEKA, QH^TM^) was added to a standard laboratory mouse diet (powdered CE-2, CLEA, Osaka, Japan) at a concentration of 0.2% with corn oil (1%, v/w). The only corn oil (1%, v/w) was used as a vehicle in the control diet. The mixture was incorporated in pellet-type chow by adding 30% ethanol solution (v/v), pressure shaping and drying. In general, body weights and food consumption of the mice were calculated every second day, while mice were inspected daily. After 7-day supplementation period with ubiquinol or the respective control diet, animals were sacrificed by anesthesia using isoflurane gas. Livers were removed and the outer left lobes were stored in RNA-*later* Storage Solution (Qiagen, Tokyo, Japan) until use for gene expression and methylation analyses.

Microarray analysis
-------------------

Microarray analysis was conducted on four samples for each group, respectively, by using GeneChip® Mouse Genome 430 2.0 Array (Affymetrix, High Wycombe, United Kingdom) containing 45,100 probe sets. Initially, total RNA was extracted from liver tissues with the miRNeasy kit (Qiagen, Hilden, Germany). The following procedure was performed according to manufacturer's instructions using Poly-A RNA Control Kit (Affymetrix) and One-Cycle cDNA Synthesis Kit (Affymetrix) for cDNA synthesis, Sample Cleanup Module (Affymetrix) for purification, and IVT Labeling Kit (Affymetrix) for synthesis of biotin-labeled cRNA. Fifteen µg of fragmented cRNA was hybridized to a Mouse Genome 430 2.0 Array for 16 h at 45°C at 60 rpm. Subsequently thereafter, arrays were washed and stained using Fluidics Station 450. Hybridization, washing and staining solutions were obtained from analogous GeneChip® kits. After hybridization and washing procedures, microarrays were scanned with the GeneChip® scanner 3000, using GCOS software. If not stated otherwise, all kits and equipment were purchased from Affymetrix. Fluorescence data were obtained in CEL file format. Quality control and normalization procedure of the files was performed with R software 2.7.1 and BioConductor 2.0.1 provided by the MADMAX database (https://madmax.bioinformatics.nl). Data were normalized with the GC-RMA algorithm. Only probe sets showing present calls for all arrays at one experimental group (intervention or control) were considered for further analysis. The complete datasets will be submitted to NCBI Gene Expression Omnibus (GEO).

qRT-PCR
-------

Primer sequences for real-time quantitative RT-PCR (qRT-PCR) experiments were designed with Primer Express® Software 3.0 (Applied Biosystems, Darmstadt, Germany). Primer pairs (5\'-3\') for NELF (forward: GAACCCCGAGCCGAATG, reverse: CCGTTAGGGTTCCCCAGAAT) and GPX3 (forward: ACAGGAGCCAGGCGAGAA, reverse: CCACCTGGTCGAACATACTTGA) were obtained from MWG Biotech AG (Ebersberg, Germany). cDNA synthesis was initially carried out with the reverse transcriptase core kit (Eurogentec, Köln, Germany) on a thermocycler (Biometra, Göttingen, Germany). qRT-PCR amplification was performed with the Power SYBR® Green PCR Master Mix (Applied Biosystems, Darmstadt, Germany) on an Applied Biosystem 7300 qRT-PCR system. Ct-values of target genes were related to those of the corresponding housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).

Text mining analysis
--------------------

For analysis of common pathways between regulated genes, Genomatix software 2010 (www. genomatix.de) was used. Probe set IDs of the selected genes were uploaded to BibliospherePathwayEdition (BSPE) software. This text mining tool identifies putative functional connections of genes based on co-citations with transcription factors and other genes in the network from NCBI PubMed. The most stringent co-citation filter restricted to sentences with expert curated information (level B4) was applied.

Promoter DNA-methylation analysis
---------------------------------

The presence of CpG islands within the ABCA1, ACSL1 and ACYP1 gene promoters was predicted by EMBOSS CpGplot program. Quantitative methylation analysis of the three genes was performed with the MassARRAY® system (Sequenom, Hamburg, Germany). The MassCLEAVE^TM^ biochemistry was applied after bisulfite treatment of DNA samples and MALDI-TOF mass spectrometry for analyte detection according to the standard protocols recommended by the supplier. Genomic DNA was extracted from mice liver with the DNeasy Kit (Qiagen). One microgram DNA was treated with sodium bisulfate (DNA Bisulfite Treatment Kit, Sequenom, Hamburg, Germany) and target regions of the modified nucleic acid were amplified by PCR using methylation independent primers, designed by the MassARRAY platform specific EpiDesigner software (Table 2). The PCR products were then subjected to *in vitro* transcription with RNase A cleavage being used for the T-reverse reaction (Sequenom). The generated fragments were displayed based on their molecular weight in the mass spectrum, which was acquired after sample conditioning with a MassARRAY® Analyzer Compact. The resulting methylation calls were analyzed with EpiTyper Software (Sequenom) to generate quantitative results for each CpG site.

Statistics
----------

If not stated otherwise, data are expressed as means ± SEM of four mice per each group, respectively. Differences between ubiquinol-treated and non-treated animals were analyzed by an unpaired two-tailed Students *t* test. *p* values less than or equal to 0.05 were considered as significant.

Results and Discussion
======================

Ubiquinol supplementation reveals no impact on body weight changes
------------------------------------------------------------------

Eight male C57BL6J mice were received at the age of 10 weeks, and initially maintained for 1-week acclimation period. Immediately thereafter, mice were randomly grouped (*n* = 4 for each group) and either supplemented with ubiquinol (250 mg/kg/d) or a respective control diet for one week. As indicated in Fig. [1](#F1){ref-type="fig"}, body weights slightly increased both in the subsequently treated ubiquinol group and in control animals during acclimation period from day 1 (−6) to day 7 (0) from 22.15 ± 0.26 g and 22.68 ± 0.44 g to 22.9 ± 0.29 g (*p* = 0.0032) and 23.53 ± 0.60 g, respectively. Increases in body weights were obtained during grouping period (from day 0 to day 1) in both groups with total values of 24.43 ± 0.25 g in the ubiquinol group and 24.38 ± 0.11 g in control animals. No significant changes of body weights have been found during supplementation period from day 1 until sacrifice of mice (day 8) both in ubiquinol-treated and control animals. The final body weights were 25.15 ± 0.15 g and 24.73 ± 0.34 for treatment and control animals, respectively, and are thus comparable to age-matched C57BL6J mice described in the literature.^([@B6])^ Finally, at any indicated time point, no significant differences in body weights were found between treatment and control group. Hence, subsequently described effects of ubiquinol supplementation on gene expression and promoter methylation patterns cannot be simply ascribed to changes in weight.

Whole genome expression data reveal effects of ubiquinol supplementation on liver lipid metabolism
--------------------------------------------------------------------------------------------------

Microarray-based whole genome expression profiles were analyzed from liver samples of mice either supplemented with ubiquinol (250 mg/kg body weight/d) or a respective control diet for one week. Samples were taken from four mice per each group respectively, resulting in a total of eight microarrays. Differentially expressed genes between ubiquinol-treated and control animals were selected as follows: Initially transcripts with at least four present calls (100%) in one group (treatment or control) were chosen for further analysis. Secondly, transcripts showing at least a 1.5-fold increase or decrease in the ubiquinol-treated animals when related to controls (*p*⩽0.05, Students *t* test) were selected. Based on these criteria, 1112 and 571 transcripts were up- and down-regulated by ubiquinol, respectively. To study the observed effects of ubiquinol supplementation on gene expression in more detail, transcripts with the highest fold change values ("Top 20", *p*⩽0.05) were selected. However, before unravelling putative functional connections among these genes, the accuracy of microarray data was verified by qRT-PCR for two selected "top 20" genes, namely glutathione peroxidase 3 (GPX3) and nasal embryonic LHRH factor (NELF) (Fig. [2](#F2){ref-type="fig"}). In brief, GPX3 has been described to mediate PPARγ-associated antioxidant effects in human muscle cells and plasma.^([@B15])^ Additionally, an influence on the regulation of local and systemic oxidative stress processes has been described.^([@B16])^ In this context, effects of ubiquinol supplementation on hepatic oxidative stress-associated gene regulation has been already described previously.^([@B6])^ The NELF gene is primarily expressed in olfactory sensory cells and LHRH cells during embryonic development,^([@B17])^ and is therefore ascribed as an important factor in the developmental migration process. In adult tissue, NELF has been also shown to be present in the liver.^([@B17])^ In summary we could show that the fold change values of the two selected "top 20" genes glutathione peroxidase 3 (GPX3) and nasal embryonic LHRH factor (NELF) (Fig. [2](#F2){ref-type="fig"}) were in accordance to the microarray data (Table [1](#T1){ref-type="table"}). To determine functional connections between the "top 20" up- and down-regulated genes, text mining analysis was subsequently performed by the use of Genomatix BibliospherePathwayEdition Software including GFG level B4. Based on these stringent criteria, three ubiquinol-sensitive genes \[ATP-binding cassette, sub-family A (ABC1), member (ABCA1), stearoyl-Coenzyme A desaturase 1 (SCD1) and glycerol-3-phosphate acyltransferase (GPAM)\] were functionally connected with each other in the PPARα signalling pathway (Fig. [3](#F3){ref-type="fig"}). Moreover, when related to GeneOntology terms (Table [1](#T1){ref-type="table"}), 6 (15%) of the "top 20" up- and down-regulated genes were related to cholesterol or lipid metabolism. These results suggest a functional role of ubiquinol in cholesterol and/or lipid metabolism and are, inter alia in agreement to a previous performed supplementation study with ubiquinol in senescence accelerated mice prone (SAMP1). In this study, various genes with a functional role in cholesterol synthesis, fat assimilation and lipoprotein metabolism have been shown to be affected.^([@B4])^ Moreover, these transcriptional effects were also translated into physiological readouts of cholesterol metabolism *in vivo*.^([@B18])^ In summary, our present and previous data show both short and long-term effects of ubiquinol supplementation on genes involved in liver lipid and/or cholesterol metabolism.

Ubiquinol-induced effects on gene expression are not mediated by changes in promoter methylation
------------------------------------------------------------------------------------------------

With regard to the functional analysis of the microarray data from liver tissues of ubiquinol-supplemented mice, distinct effects on genes related to lipid and/or cholesterol metabolism were found (Table [1](#T1){ref-type="table"}, Fig. [3](#F3){ref-type="fig"}). Because transcriptional variation has been correlated with CpG island variation^([@B19])^ and previous literature reports have documented distinct roles of various micronutrients in the epigenetic regulation of gene expression,^([@B20]--[@B23])^ CpG island regions in promoter regions of three regulated genes strongly related to lipid metabolism were analyzed for putative changes by using base-specific cleavage and matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry. In general, as an essential precondition, all three genes show CpG islands in their promoter regions and could be therefore selected for DNA methylation analysis. Based on these criteria and the results from microarray experiments, the following ubiquinol-regulated genes (*p*⩽0.05) were finally selected for subsequent methylation analysis: ABCA1 (ATP-binding cassette, sub-family A, member 1), ACSL1 (Acyl-CoA Synthetase long-chain family member 1) and ACYP1 (Acylphosphatase 1). These genes have been shown to be regulated about +3.14-fold (*p*⩽0.05), −2.13-fold (*p*⩽0.05) and +2.18-fold (*p*⩽0.01), respectively, when related to liver samples of control mice. In brief, the ABCA1 gene is a LXR target gene and plays an important role in reverse cholesterol transport.^([@B24])^ ACSL1 plays an important role in fatty acid metabolism and triacylglycerol synthesis.^([@B25])^ Disturbances of these pathways may result in e.g. dyslipidemia, one hallmark of the metabolic syndrome.^([@B26])^ ACYP1 primarily mediates hydrolytic activity on e.g. acyl phosphates and aryl phosphate monoesters.^([@B27])^ Overall, our DNA methylation analysis at 282 (sense orientation) and 271 (antisense orientation) CpG units, spanning nucleotides relatively to the gene start position from −748 to 1,391 for ABCA1 gene (Fig. [4](#F4){ref-type="fig"}A), from −552 to 819 for ACSL1 gene (Fig. [4](#F4){ref-type="fig"}B), and from −6,863 to --7,663 as well as −298 to 336 for ACYP1 gene (Fig. [4](#F4){ref-type="fig"}C) revealed no differences between Q~10~H~2~-treated and control animals. From these results, no significant differences in the promoter methylation patterns of ABCA1, ACSL1 and ACYP1 genes could be detected with regard to a short term supplementation period with ubiquinol in C57BL6J mice.[](#T2){ref-type="table"}

Although we could not found any significant effects of ubiquinol supplementation on CpG island promoter region methylation patterns of ABCA1, ACSL1 and ACYP1 genes, previous results in the literature show that coenzyme Q~10~ containing coenzyme supplementation is able to induce the disappearance of tamoxifen-induced RASSF1A DNA methylation patterns in breast cancer patients.^([@B28])^ Moreover, this supplementary therapy has also been shown to counteract the tamoxifen-induced increased lipoprotein and lipid levels in these patients.^([@B28])^ By the way, ubiquinol-induced reductions of LDL cholesterol levels have been also observed previously in healthy male volunteers.^([@B5])^ From these results it seems that ubiquinol supplementation may modulate lipid metabolism through an impact on DNA methylation patterns. Although we could not find any ubiquinol-induced supplementary effects in the present study, it can not be ruled out that changes in the methylation pattern other than in the promoter region of ABCA1, ACSL1 and ACYP1 genes have led to the observed differences on gene expression. In fact, effects on global methylation patterns have been already described for several other dietary supplements and micronutrients in the literature.^([@B20],[@B21],[@B29]--[@B32])^ Thus, a global methylation analysis would be required to finally answer the question of a ubiquinol-dependent epigenetic regulation of ABCA1, ACSL1 and ACYP1 genes. Moreover, the observed changes in gene expression might be also mediated through modifications of histones by acetylation, methylation, phosphorylation, ubiquitination, sumoylation or isomerisation.^([@B22],[@B23])^ The ability of dietary compounds to influence epigenetic processes via histone modification has been already described *in vitro*and *in vivo*.^([@B32],[@B33])^ However, the translation of these findings into clinical health applications is still a remaining challenge for further studies in the future.

In summary, we could show that one-week supplementation with ubiquinol (250 mg/kg BW/d) induces a gene expression pattern in liver tissues of C57BL6J mice with a functional role in PPARα signalling, lipid and/or cholesterol metabolism. Because transcriptional variation has been correlated with CpG island variation, CpG island regions in promoter regions of three regulated genes (ABCA1, ACSL1 and ACYP1) with a relevant impact in lipid and/or cholesterol metabolism were analyzed. However, promoter DNA methylation analysis of ABCA1, ACSL1 and ACYP1 promoters in the liver of C57BL6J mice revealed no differences between ubiquinol-treated and control mice. Thus, ubiquinol affects the expression of genes involved in PPARα signalling and lipid metabolism without changes in promoter DNA methylation in the liver of mice.
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![Body weight development of 10-week old C57BL6J mice during acclimation period and one-week supplementation period with ubiquinol (250 mg/kg/d) or a respective control diet. Body weights of Q~10~H~2~-treated and control animals increased slightly during acclimation period (from day 1 \[−6\] to day 7 \[0\]). Strong increases in body weights were obtained during grouping period (from day 0 to day 1) in both groups. No significant changes of body weights have been found during supplementation period from day 1 until sacrifice of mice (day 8) both in the ubquinol-treated (+Q~10~H~2~) and control group (−Q~10~H~2~).](jcbn11-19f01){#F1}

![Verification of selected "top 20" genes from microarray experiments by qRT-PCR. For verification of microarray data, two "top 20" up-regulated genes (GPX3, NELF) were further selected for qRT-PCR experiments. Finally, GPX3 (A) and NELF (B) genes were up-regulated about 2.0-fold (*p* = 0.0196) and 1.3-fold (*p* = 0.026) in the ubiquinol-treated (+Q~10~H~2~) animals, respectively, when related to control mice (−Q~10~H~2~).](jcbn11-19f02){#F2}

![Bibliosphere network of ubiquinol-sensitive genes regulated in liver tissues of C57BL6J mice. Based on co-citations with transcription factors and other genes in the network (GFG level B4), 3 ubiquinol-inducible genes were connected with each other by BibliospherePathwayEdition Software. According to this, the uploaded genes seem to play a key role in PPAR-α signalling pathways. IN, input gene; TF, transcription factor; M, gene product is part of a metabolic pathway; ST, gene product is part of a Genomatix signal transduction pathway.](jcbn11-19f03){#F3}

![Schematic overview of amplicons processed for ABCA1 (A), ACSL1 (B) and ACYP1 (C) analyses in the genomic context. Positions are relative to the selected input region (indicated as reg) and correspond to Table [2](#T2){ref-type="table"} for each respective gene. The regions are located for ABCA1 (A) and ACSL1 (B) gene at position −748 to 1391 and −552 to 819, respectively, when related to the gene start position. For ACYP1 gene (C), region 01 (upper portion) and region 02 (lower portion) are located at position −6863 to −7663 and −298 to 336, respectively, when related to the gene start position. All genes are shown in their transcribed orientation, which is located for ABCA1 and ACYP1 on the antisense strand of chromosome 4 and 12, respectively. For ACSL1 gene, the transcribed orientation is shown on the sense strand of chromosome 8.](jcbn11-19f04){#F4}

![Epigram of quantitative methylation analysis of promoter regions in ABCA1, ACSL1 and ACYP1 genes. Genomic DNA isolated from liver samples of Q~10~H~2~ supplemented (14, 17, 20, 23) and non-supplemented control mice (38, 41, 44, 47) was analyzed for methylation status of 553 (sense and antisense) CpG sites of the (A) ABCA1, (B) ACSL1 and (C) ACYP1 gene promoter. Exemplary data for one amplicon of each gene is shown. The coloured dots indicate the software determined methylation ratio at each analyzed CpG-unit for each sample. nc_001 represents the reaction negative control (water) and DNA-meth the artificially completely methylated control DNA. The reference sequence above the epigram corresponds to the genomic sequence of the analyzed strand. Displayed is the sense orientation in 5\' → 3\' direction. Base numbering in the epigram refers to the analyzed amplicon.](jcbn11-19f05){#F5}

###### 

Display of the "top 20" up- and down-regulated genes in liver samples of mice supplemented with ubiquinol for 7 days

  Affymetrix Probe Set ID          FC       *p* value   Gene symbol     Gene name                                                                                            GeneOntology Process/Function
  -------------------------------- -------- ----------- --------------- ---------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *up-regulated genes*                                                                                                                                                       
   1451488_at                      6.67     0.04        FITM1           fat storage-inducing transmembrane protein 1                                                         Lipid particle organization, positive regulation of sequestering of triglyceride
   1439398_x\_at                   5.82     0.0001      Nelf            Nasal embryonic LHRH factor                                                                          
   1452637_a\_at                   5.09     0.02        Bola1           Bola-like 1 (*E. coli*)                                                                              biological process, molecular function
   1428554_a\_at                   4.59     0.04        1810035L17Rik   RIKEN cDNA 1810035L17 gene                                                                           Biological process, regulation of transcription, RNA-binding, molecular function, nucleic acid binding, nucleotide binding
   1416439_at                      4.57     0.01        Dctpp1          dCTP pyrophosphatase 1                                                                               Nucleoside triphosphate catabolic process, protein homotetramerization, dCTP diphosphatase activity, hydrolase activity, metal ion binding
   1428464_at                      4.48     0.05        Ndufa3          NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3                                                Biological process, electron transport chain, transport, molecular function
   1420952_at                      4.26     0.04        Son             Son cell proliferation protein                                                                       DNA binding, RNA binding, nucleic acid binding, protein binding
   1438403_s\_at                   4.24     0.04        ---             ---                                                                                                  
   1422608_at                      4.14     0.02        Arpp19          cAMP-regulated phosphoprotein 19                                                                     positive regulation of Ras protein signal transduction, molecular function
   1449106_at                      4.1      0.05        Gpx3            glutathione peroxidase 3                                                                             Glutathione metabolic process, hydrogen peroxide metabolic process, oxidation reduction, response to oxidative stress, glutathione binding, peroxidase activity, oxidoreductase activity
   1421374_a\_at                   4.01     0.03        Fxyd1           FXYD domain-containing ion transport regulator 1                                                     Cellular calcium ion homeostasis, ion transport, muscle contraction, transport, chloride channel activity, ion channel activity
   1416217_a\_at                   4        0.05        Rpl37a          ribosomal protein L37a                                                                               biological process, molecular function
   1434823_x\_at                   3.91     0.02        Myeov2          myeloma overexpressed 2                                                                              biological process, molecular function
   1436757_a\_at                   3.91     0.03        Cox6b1          cytochrome c oxidase, subunit VIb polypeptide 1                                                      cytochrome-c oxidase activity
   1420642_a\_at                   3.91     0.05        Romo1           reactive oxygen species modulator 1                                                                  biological process, molecular function
   1448685_at                      3.88     0.04        2900010M23Rik   RIKEN cDNA 2900010M23 gene                                                                           biological process, molecular function
   1438655_a\_at                   3.86     0.04        Rpl34           ribosomal protein L34                                                                                biological process, molecular function
   1431199_at                      3.84     0.04        Ggnbp1          gametogenetin binding protein 1                                                                      Cell differentiation, mitochondrial fission, multicellular organismal development, spermatogenesis, protein binding
   1416285_at                      3.82     0.04        Ndufc1          NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1                                             biological process, electron transport chain, transport, molecular function
   1429453_a\_at                   3.8      0.02        Mrpl55          mitochondrial ribosomal protein L55                                                                  biological process, molecular function
                                                                                                                                                                             
  *down-regulated genes*                                                                                                                                                     
   1452391_at                      --3.37   0.002       Cxadr           Coxsackie virus and adenovirus receptor                                                              cardiac muscle fiber development, cell adhesion, cell-cell junction organization, heart development, mitochondrial organization, negative regulation of cardiac muscle cell proliferation, protein binding, receptor activity
   1450392_at                      --3.15   0.02        Abca1           ATP-binding cassette, sub-family A (ABC1), member 1                                                  cholesterol efflux, cholesterol transport, lipoprotein biosynthetic process, phospholipids efflux, positive regulation of cholesterol efflux, protein amino acid lipidation, ATP binding, ATPase activity, cholesterol transporter activity
   1427408_a\_at                   --2.91   0.02        Thrap3          thyroid hormone receptor associated protein 3                                                        positive regulation of transcription from RNA polymerase II promoter, transcription coactivator activity
   1417015_at                      --2.84   0.04        Rassf3          Ras association (RalGDS/AF-6) domain family 3                                                        biological process, signal transduction, molecular function, protein binding
   AFFX-PyruCarbMur/L09192_5\_at   --2.7    0.04        Pcx             pyruvate carboxylase                                                                                 gluconeogenesis, lipid biosynthetic process, metabolic process, oxaloacetate metabolic process, pyruvate metabolic process, ATP binding, biotin binding, metal ion binding, pyruvate carboxylase activity, nucleotide binding
   1425461_at                      --2.67   0.02        Fbxw11          F-box and WD-40 domain protein 11                                                                    Wnt receptor signalling pathway, biological process, cell cycle, rhythmic process, molecular function
   1420948_s\_at                   --2.61   0.002       Atrx            alpha thalassemia/mental retardation syndrome X-linked homolog (human)                               DNA repair, forebrain development, response to DNA damage stimulus, ATP binding, DNA binding, chromatin binding, metal ion binding
   1433515_s\_at                   --2.6    0.01        Etnk1           ethanolamine kinase 1                                                                                biological process, phospholipid biosynthetic process, ATP binding, ethanolamine kinase activity, kinase activity, molecular function, nucleotide binding, transferase activity
   1425834_a\_at                   --2.6    0.05        Gpam            glycerol-3-phosphate acyltransferase, mitochondrial                                                  Acyl-CoA metabolic process, cellular response to insulin stimulus, defense response, fatty acid homeostasis, glycerophospholipid metabolic process, triglyceride metabolic process, phospholipid homeostasis, regulation of cytokine secretion, acyltransferase activity
   1430991_at                      --2.56   0.03        1810014B01Rik   RIKEN cDNA 1810014B01 gene                                                                           biological process, molecular function
   1424484_at                      --2.55   0.04        Mobkl1b         MOB1, Mps One Binder kinase activator-like 1B (yeast)                                                metal ion binding, protein binding
   1448158_at                      --2.49   0.04        Sdc1            syndecan 1                                                                                           canonical Wnt receptor signaling pathway, myoblast development, cytoskeletal protein binding, glycoprotein binding
   1422862_at                      --2.45   0.02        LOC669660       similar to PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein)   
   1420864_at                      --2.43   0.0003      Zfp161          zinc finger protein 161                                                                              Regulation of transcription, DNA binding, metal ion binding, nucleic acid binding, protein binding, zinc ion binding
   1415965_at                      --2.4    0.004       Scd1            stearoyl-Coenzyme A desaturase 1                                                                     Brown fat cell differentiation, cholesterol esterification, fatty acid biosynthetic process, lipid metabolic process, oxidation reduction, white fat cell differentiation, oxidoreductase activity, stearoyl-CoA9-desaturase activity, iron ion binding
   1431096_at                      --2.4    0.04        Ints8           integrator complex subunit 8                                                                         biological process, molecular function
   1419816_s\_at                   --2.39   0.004       Errfi1          ERBB receptor feedback inhibitor 1                                                                   lung alveolus development, negative regulation of epidermal growth factor receptor activity, regulation of keratinocyte differentiation, stress-activated protein kinase signalling cascade, kinase binding, protein binding, receptor activity
   1420927_at                      --2.38   0.03        St6gal1         beta galactoside alpha 2,6 sialyltransferase 1                                                       metabolic process, protein amino acid glycosylation, sialyltransferase activity
   1448607_at                      --2.37   0.004       Nampt           nicotinamide phosphoribosyltransferase                                                               NAD biosynthetic process, positive regulation of muscle cell proliferation, pyridine nucleotide biosynthetic process, cytokine activity, nicotinamide phosphoribosyltransferase activity, protein homodimerization activity
   1418279_a\_at                   --2.36   0.01        Akap1           A kinase (PRKA) anchor protein 1                                                                     Negative regulation of NFAT protein import into nucleus, negative regulation of protein amino acid dephosphorylation, RNA binding, kinase activity, nucleic acid binding

\# presented by ≥2 probe set Ids in Top 20 gene list.

###### 

PCR primers for analysis of the methylation status of (A) ABCA1, (B) ACSL1 and (C) ACYP1 gene promoters. All positions are relative to the entire input sequences

  \(A\) ABCA1                                                                 
  --------------------- ------ ------ ----- ---- ---------------------------- -----------------------------
  *forward direction*                                                         
   ABCA1_amp01          50     506    457   8    GGTTTTTGGAAGGTAGAGATTTTTT    CCCTAACCCTAACCTACTAACCTTC
   ABCA1_amp02          482    1101   620   40   GAAGGTTAGTAGGTTAGGGTTAGGG    CCCTATACTATTTACATCCCCAAAAA
   ABCA1_amp03          1076   1515   440   21   TTTTTGGGGATGTAAATAGTATAGGG   CCCAAAAAACTCAAACAACAATAAC
   ABCA1_amp04          1424   1967   544   22   GATTGGGATTGTATGTTTTTGTTTT    CACCAATTTTAACCAAATTCACAAT
                                                                              
  *reverse direction*                                                         
   ABCA1_amp05          115    516    402   8    TTTTTTGTAGTTTTGGTTTTGATTTG   AAACTAATATTCACTATCCATTCCACA
   ABCA1_amp06          491    891    401   36   GGGGGAAATAGGGAGTAGAGTAGTT    CAAATCAAAACCAAAACTACAAAAA
   ABCA1_amp07          865    1367   503   23   AGGATTTAGATGTGATATTTGTGGG    AAAACTACTCTACTCCCTATTTCCCC
   ABCA1_amp08          1343   1669   327   7    AGGGTGGATTGGGTATTTTAGTTT     CCCACAAATATCACATCTAAATCCT
   ABCA1_amp09          1646   2084   439   17   GGTTTGGGAGTTAGGAAATAAATAAA   AAACTAAAATACCCAATCCACCCT

  \(B\) ACSL1                                                                   
  --------------------- ------ ------ ----- ---- ------------------------------ ------------------------------
  *forward direction*                                                           
   ACSL1_amp01          27     390    364   13   AGGATGGAAGAGTTAAAGGGTATTT      TATCTAAACTAATCCAAACCCCTCA
   ACSL1_amp02          366    1078   713   78   TGAGGGGTTTGGATTAGTTTAGATA      CAAAATCCCCAACAAACAAAA
   ACSL1_amp03          1049   1278   230   22   GAGAGGTGGTTTTGTTTGTTGG         TCTAAAAACTCCTCTTAAAAACACC
                                                                                
  *reverse direction*                                                           
   ACSL1_amp04          87     387    301   13   TTGGGTTGATTTAAGTTTTTTAGATT     AAAACTTCCAAATTTACCCTTTACC
   ACSL1_amp05          364    1077   714   78   AGGGTTTTTAGTAAGTAGGATTATTTTT   TCTAAAAAACTTAAATCAACCCAAA
   ACSL1_amp06          1050   1290   241   22   GTGTGTAGTGGTTTTGGGAGTTT        AAAAATAATCCTACTTACTAAAAACCCT

  \(C\) ACYP1                                                                 
  --------------------- ----- ----- ----- ---- ------------------------------ -----------------------------
  Region 01                                                                   
                                                                              
  *forward direction*                                                         
   ACYP1_amp01          142   729   588   29   GAGAGGGGGTGATAGATATTTGAG       AATATAACCCCAAAAAAACCTCTCC
   ACYP1_amp02          767   945   179   7    AGATTTTAGGGTGTGTTTTTGTTTG      CCTAAAACTCTTACATAACCCTACCT
                                                                              
  *reverse direction*                                                         
   ACYP1_amp03          76    355   280   12   TGGGGATTTTTTTTGAGTTGGAG        TCAAACCCTCATACAAAAATACTCTAT
   ACYP1_amp04          344   943   600   26   TGGAGTTTTTATATAGTTTTATTTGGGG   AAAAAATCCCCAAAACCTAATTTTC
                                                                              
  Region 02                                                                   
                                                                              
  *forward direction*                                                         
   ACYP1_amp05          11    394   384   16   TTTTAGGTATTTAGTAGGGTGAGTGGA    ATTTCTAAAACTTCCCCAAAAACC
   ACYP1_amp06          195   599   405   26   ATTTGTTTTGAAGTTTTATTTTTGGG     CTCCAATACCATAAAAACCTCTCC
                                                                              
  *reverse direction*                                                         
   ACYP1_amp07          1     601   601   29   TTTTTTAATATTATGGGGGTTTTTT      ATACTAACAACCCTAAACACCCAA
